https://www.adnkronos.com/salute/risultati-positivi-per-tozorakimab-nella-riduzione-delle-riacutizzazioni-per-la-bpco_1R0NulYuPmoy1LxB6G3cqg
Risultati positivi per tozorakimab nella riduzione delle riacutizzazioni nella Bpco
AstraZeneca: 'Potenziale biologico first-in-class con meccanismo d'azione realmente differenziato'
risultatipositivipertozorakimabnella
https://www.miragenews.com/tozorakimab-hits-primary-goal-in-copd-phase-iii-1658188/
Tozorakimab Hits Primary Goal in COPD Phase III Trial | Mirage News
Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically
phase iii trialtozorakimabhitsprimarygoal
https://www.barchart.com/story/news/1001706/tozorakimab-met-primary-endpoint-in-both-oberon-and-titania-phase-iii-trials-in-patients-with-copd
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate...